These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20008985)

  • 1. Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products.
    Thakur ML; Devadhas D; Zhang K; Pestell RG; Wang C; McCue P; Wickstrom E
    J Nucl Med; 2010 Jan; 51(1):106-11. PubMed ID: 20008985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VPAC1 receptors for imaging breast cancer: a feasibility study.
    Thakur ML; Zhang K; Berger A; Cavanaugh B; Kim S; Channappa C; Frangos AJ; Wickstrom E; Intenzo CM
    J Nucl Med; 2013 Jul; 54(7):1019-25. PubMed ID: 23651947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting VPAC1 Receptors for Imaging Glioblastoma.
    Tripathi SK; Kean R; Bongiorno E; Hooper DC; Jin YY; Wickstrom E; McCue PA; Thakur ML
    Mol Imaging Biol; 2020 Apr; 22(2):293-302. PubMed ID: 31292914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.
    Tripathi S; Trabulsi EJ; Gomella L; Kim S; McCue P; Intenzo C; Birbe R; Gandhe A; Kumar P; Thakur M
    Urology; 2016 Feb; 88():111-8. PubMed ID: 26519886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC1 Targeted
    Tripathi SK; Kumar P; Trabulsi EJ; Kim S; McCue PA; Intenzo C; Berger A; Gomella L; Thakur ML
    Nucl Med Biol; 2017 Aug; 51():55-61. PubMed ID: 28577428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.
    Zhang K; Aruva MR; Shanthly N; Cardi CA; Rattan S; Patel C; Kim C; McCue PA; Wickstrom E; Thakur ML
    J Nucl Med; 2008 Jan; 49(1):112-21. PubMed ID: 18077536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation.
    Zhang K; Aruva MR; Shanthly N; Cardi CA; Patel CA; Rattan S; Cesarone G; Wickstrom E; Thakur ML
    Regul Pept; 2007 Dec; 144(1-3):91-100. PubMed ID: 17727979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen.
    Truong H; Gomella LG; Thakur ML; Trabulsi EJ
    World J Urol; 2018 May; 36(5):719-726. PubMed ID: 29541892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
    Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
    J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice.
    Moody TW; Dudek J; Zakowicz H; Walters J; Jensen RT; Petricoin E; Couldrey C; Green JE
    Life Sci; 2004 Jan; 74(11):1345-57. PubMed ID: 14706566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
    Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
    J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression of vasoactive intestinal peptide receptors in human lung cancer.
    Szilasi M; Buglyo A; Treszl A; Kiss L; Schally AV; Halmos G
    Int J Oncol; 2011 Oct; 39(4):1019-24. PubMed ID: 21769421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.